跳至主要内容
临床试验/CTRI/2012/10/003063
CTRI/2012/10/003063招募中3 期

A Double Blind, placebo controlled, Clinical study to evaluate the efficacy and safety of Ginger caplets in Post operative nausea and vomiting

The Himalaya Drug Company0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients who are posted for abdominal surgery, hernia, orthopedic and gynecological surgeries and also those patients presenting with Post operative nausea & vomiting.
  • Patients willing to sign informed consent.

排除标准

  • Patients with severe vomiting related to CNS or severe gastrointestinal disorders.
  • Any evidence or history of hypersensitivity to herbal medicines.
  • Not willing to sign the informed consent or abide by the study procedure.
  • Pregnant or lactating women

研究者

相似试验